Treatment of Gonorrhoea in Disseminated Gonococcal Infection

Gonorrhoea presenting as disseminated gonococcal infection (DGI) is a distinct clinical situation that requires a dedicated treatment approach. The syndrome type seen at presentation directly influences the route, duration, and step-down strategy for antibiotic therapy.

Clinical scenario — disseminated gonococcal infection

Two distinct clinical syndromes are classically described in DGI: a triad of tenosynovitis, polyarthralgia, and dermatitis; or purulent arthritis, with or without additional symptoms. Recognising which syndrome is present is central to determining the management pathway.

Treatment approach

Initial management involves parenteral antibiotic therapy. Once adequate clinical improvement is documented, a structured step-down to an appropriate oral regimen becomes possible — but the specific agents, criteria, and timing are laid out in full in the protocol.

Clinical goals

The therapeutic target is improvement of arthritis and arthritis-dermatitis symptoms to a degree that safely permits a switch to oral therapy within 24–48 hours of demonstrable response.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1177/09564624251345195

Two distinct clinical syndromes are classically described in DGI: a triad of tenosynovitis, polyarthralgia and dermatitis, or purulent arthritis with or without additional symptoms.

Ceftriaxone 1 g IM or IV every 24 h (GRADE 1D).

For arthritis and arthritis-dermatitis syndrome, therapy should continue for 7 days but may be switched 24–48 h after symptoms improve to oral cefixime 800 mg twice daily or ciprofloxacin 500 mg twice daily if the isolate is susceptible (note warning above for fluoroquinolones).

View source ↗